535.00p-5.00 (-0.93%)29 Nov 2021, 18:00
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Silence Therapeutics PLC Market & Company News

26.11.2021 07:00Update on AIM DelistingRNS
25.11.2021 17:30PANR, SQZSilence TherapeuticsRNS
16.11.2021 07:00Third Quarter 2021 Financial ResultsRNS
11.11.2021 07:00Silence to Present at Jefferies London ConferenceRNS
10.11.2021 07:00Holding(s) in CompanyRNS
05.11.2021 07:00New Key ShareholderRNS
01.11.2021 17:33Result of General MeetingRNS
01.11.2021 16:49Total Voting RightsRNS
28.10.2021 16:02Holding(s) in CompanyRNS
21.10.2021 13:30Silence Provides Pipeline Updates at 2021 R&D DayRNS
15.10.2021 07:05Proposed Cancellation of Trading on AIMRNS
15.10.2021 07:00Silence and Hansoh Pharma Announce CollaborationRNS
08.10.2021 07:00Block Listing ReturnRNS
08.10.2021 07:00Total Voting RightsRNS
07.10.2021 07:00Silence Therapeutics to host R&D dayRNS
28.09.2021 07:00Chardan Genetic Medicines Conference ParticipationRNS
08.09.2021 16:03Holding(s) in CompanyRNS
08.09.2021 16:00Holding(s) in CompanyRNS
01.09.2021 07:00Silence Appoints Senior VP of BD, AM and NPD.RNS
25.08.2021 07:00Silence to Participate in Investor ConferencesRNS
12.08.2021 07:00Silence Therapeutics Report Half-Year 2021 ResultsRNS
06.08.2021 12:15Holding(s) in CompanyRNS
06.08.2021 12:13Holding(s) in CompanyRNS
05.08.2021 14:57Total Voting RightsRNS
15.07.2021 07:00Notice of half year resultsRNS
15.06.2021 17:54Results of Annual General MeetingRNS
07.06.2021 07:00Silence to present SL124 data at EHARNS
25.05.2021 07:00$40m Payment from AstraZeneca for CollaborationRNS
19.05.2021 07:00Phase 1 Study in Healthy Volunteers Positive DataRNS
12.05.2021 07:00Silence attends RBC Global Healthcare ConferenceRNS
07.05.2021 07:00Notice of AGMRNS
04.05.2021 07:00Silence Support International Thalassemia DayReach
30.04.2021 16:12Holding(s) in CompanyRNS
29.04.2021 17:58Holding(s) in CompanyRNS
29.04.2021 07:00First patient dosed in GEMINI IIRNS
28.04.2021 07:00Silence Achieves Research Milestone PaymentRNS
27.04.2021 07:00Grant of Employee OptionsRNS
19.04.2021 07:00Purchase of ADS and PDMR ShareholdingRNS
15.04.2021 07:00Publication in Cardiovascular ResearchRNS
07.04.2021 07:00Silence to Present at Virtual Needham ConferenceRNS
30.03.2021 18:13Silence Therapeutics Publication of Annual ReportRNS
30.03.2021 09:04REPLACEMENT Silence Reports Full-year 2020 ResultsRNS
30.03.2021 07:00Silence Reports Full-year 2020 ResultsRNS
26.03.2021 07:00Block Listing ApplicationRNS
04.03.2021 07:29Silence presents at Barclays Healthcare ConferenceRNS
01.03.2021 07:00Notice of Annual ResultsRNS
26.02.2021 07:00Silence & Mallinckrodt Initiate Work on 3rd TargetRNS
24.02.2021 15:09Holding(s) in CompanyRNS
22.02.2021 07:00Silence to Partake in March Investor ConferencesRNS
18.02.2021 07:00Silence to present at SVB Leerink ConferenceRNS
17.02.2021 07:00First dosing for SLN360RNS
15.02.2021 15:55Holding(s) in CompanyRNS
15.02.2021 13:14Holding(s) in CompanyRNS
12.02.2021 16:57Holding(s) in CompanyRNS
12.02.2021 16:53Holding(s) in CompanyRNS
12.02.2021 12:10Additional Listing and Total Voting RightsRNS
11.02.2021 17:29Holding(s) in CompanyRNS
11.02.2021 11:06Holding(s) in CompanyRNS
08.02.2021 16:28Additional listing and Total Voting RightsRNS
05.02.2021 07:00Silence Announces $45m Private PlacementRNS
29.01.2021 14:35Additional listing and Total Voting RightsRNS
25.01.2021 12:41Additional listing and Total Voting RightsRNS
07.01.2021 07:00Holdings in CompanyRNS
06.01.2021 11:08Grant of OptionsRNS
06.01.2021 10:08Holding(s) in CompanyRNS
06.01.2021 07:00Silence Therapeutics Appoints Craig Tooman as CFORNS
06.01.2021 07:00Board of Directors AppointmentRNS
05.01.2021 07:00January Conference ScheduleRNS
04.01.2021 11:45Holdings in CompanyRNS
Showing 1 to 69 of 69